πŸ‡ΊπŸ‡Έ FDA
Patent

US 11919880

HCV protease inhibitors

granted A61PA61P31/14

Quick answer

US patent 11919880 (HCV protease inhibitors) held by The Regents of the University of California expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P31/14